9-氮杂双环[3.3.1]壬烷-3-酮盐酸盐 | 72761-60-5

• 物质功能分类: 有机原料 - 羧酸类化合物及衍生物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: 9-氮杂双环[3.3.1]壬烷-3-酮盐酸盐
• 英文名称: 9-azabicyclo[3.3.1]nonan-3-one hydrochloride
• 英文别名: 9-azabicyclo[3.3.1]nonan-3-one;hydrochloride
• CAS: 72761-60-5
• 化学式: C₈H₁₃NO*ClH
• 分子量: 175.658
• InChiKey: XGESYOBZBRDUBC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.28
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  29.1
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  室温和干燥环境下使用。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 9-Azabicyclo[3.3.1]nonan-3-one hydrochloride
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 9-Azabicyclo[3.3.1]nonan-3-one hydrochloride
CAS number: 72761-60-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H13NO.ClH
Molecular weight: 175.7

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  9-氮杂双环[3.3.1]壬烷-3-酮盐酸盐 在 六甲基磷酰三胺 、 正丁基锂 、 四丁基氟化铵 、 diethylzinc 、 sodium carbonate 、 (R)-N-(2,2-dimethylpropyl)-1-phenyl-2-(4-methylpiperazinyl)ethylamine 作用下， 以 四氢呋喃 、 正己烷 、 二氯甲烷 、 水 为溶剂， 反应 15.0h， 生成 (1S,2S,3R,4R,6R)-4-hydroxy-3-methyl-N-(p-tolylsulfonyl)-10-azatricyclo<4.3.1.0^2,4>decane
  参考文献：
  名称：

  Hypervalent λn-iodane-mediated fragmentation of tertiary cyclopropanol systems II: Application to asymmetric syntheses of piperidine and indolizidine alkaloids

  摘要：

  The asymmetric synthesis of (-)-pinidine and its enantiomer was accomplished by starting from norgranatanone via the asymmetric enolization, stereoselective cyclopropanation, and oxidative ring cleavage of the resulting cyclopropanol system with a hypervalent lambda(n)-iodane as key steps. Formal asymmetric synthesis of (+)-indolizidine 223AB was also performed via the asymmetric enolization and oxidative ring cleavage of the resulting cyclopropanol system as key steps. (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4020(99)00073-3
• 作为产物：
  描述：

  9-甲基-9-氮杂双环[3.3.1]壬-3-酮 在 1-氯乙基氯甲酸酯 、 甲醇 作用下， 以 甲苯 为溶剂， 反应 46.0h， 以68%的产率得到9-氮杂双环[3.3.1]壬烷-3-酮盐酸盐
  参考文献：
  名称：

  [EN] NOVEL 9-AZA-BICYCLO[3.3.1]NON-3-YLOXY CHROMEN-2-ONE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS
  [FR] NOUVEAUX DÉRIVÉS DE 9-AZA-BICYCLO[3.3.1]NON-3-YLOXY CHROMÉN-2-ONE ET LEUR UTILISATION EN TANT QU'INHIBITEURS DU RECAPTAGE DES NEUROTRANSMETTEURS MONOAMINES

  摘要：

  这项发明涉及新颖的9-aza-bicyclo[3.3.1]non-3-yloxy chromen-2-one衍生物，可用作单胺神经递质再摄取抑制剂。在其他方面，该发明涉及将这些化合物用于治疗方法以及包含该发明化合物的药物组合物。

  公开号：

  WO2009098209A1

文献信息

• AZA-BRIDGED RING-FUSED INDOLES AND INDOLINES
  申请人：Shi Lei

  公开号：US20110152306A1

  公开（公告）日：2011-06-23

  The present application relates to indole and indoline derivatives of formula (I) wherein a, R 1 , R 2 , R 3 , h, i, j, m, n, L, Q, and X are as defined in the specification. The present application also relates to compositions comprising such compounds, and methods of treating disease conditions using such compounds and compositions.

  本申请涉及式(I)的吲哚和吲哚啉衍生物，其中a、R1、R2、R3、h、i、j、m、n、L、Q和X如规范中定义。本申请还涉及包含这些化合物的组合物，以及使用这些化合物和组合物治疗疾病状况的方法。
• 5,6,7,8,9,10-hexahydro-7
  申请人：Scios Nova Inc.

  公开号：US05250537A1

  公开（公告）日：1993-10-05

  5,6,7,8,9,10-Hexahydro-7,10-iminocyclohept[b]indole, 6,7,8,9,10,11-hexahydro-7,11-imino-5H-cyclooct[b]indole and substituted derivatives are effective in the treatment of psychoses with limited liability to produce concomitant adverse extrapyramidal symptoms. These compounds are also useful for treating other central nervous system and cardiovascular disorders.

  5,6,7,8,9,10-六氢-7,10-亚胺环庚[b]吲哚，6,7,8,9,10,11-六氢-7,11-亚胺-5H-环辛[b]吲哚及其取代衍生物在治疗精神病时具有效性，且对产生并发不良的外周运动障碍症状的风险有限。这些化合物也适用于治疗其他中枢神经系统和心血管疾病。
• Bridged N-Cyclic Sulfonamido Inhibitors of Gamma Secretase
  申请人：Bowers Simeon

  公开号：US20080090817A1

  公开（公告）日：2008-04-17

  The invention provides N-cyclic sulfonamido compounds and salts of Formula I: wherein A is as described in the specification and R 1 and R 2 combine to form a [3.3.1] or a [3.2.1] ring system, where the nitrogen is attached to the two bridgehead carbons, and the [3.3.1] or [3.2.1] ring systems are optionally fused with an heteroaryl or heterocycloalkyl ring. Compounds of Formula I are useful in treating or preventing cognitive disorders, such as Alzheimer's Disease. The invention also encompasses pharmaceutical compositions comprising compounds of Formula I, methods of treating cognitive disorders, such as Alzheimer's disease, and the intermediates useful in preparing the compounds of Formula I.

  本发明提供了N-环状磺酰胺化合物和公式I的盐：其中A如规范所述，而R1和R2组合形成[3.3.1]或[3.2.1]环系统，其中氮连接到两个桥头碳，并且[3.3.1]或[3.2.1]环系统可以与杂环芳基或杂环烷基环融合。公式I的化合物可用于治疗或预防认知障碍，如阿尔茨海默病。本发明还包括包含公式I化合物的制药组合物，治疗认知障碍的方法，如阿尔茨海默病，以及制备公式I化合物的中间体。
• Bridged N-cyclic sulfonamido inhibitors of gamma secretase
  申请人：Elan Pharmaceuticals, Inc.

  公开号：US07345056B2

  公开（公告）日：2008-03-18

  The invention provides N-cyclic sulfonamido compounds and salts of Formula I: wherein A is as described in the specification and R1 and R2 combine to form a [3.3.1] or a [3.2.1] ring system, where the nitrogen is attached to the two bridgehead carbons, and the [3.3.1] or [3.2.1] ring systems are optionally fused with an heteroaryl or heterocycloalkyl ring. Compounds of Formula I are useful in treating or preventing cognitive disorders, such as Alzheimer's Disease. The invention also encompasses pharmaceutical compositions comprising compounds of Formula I, methods of treating cognitive disorders, such as Alzheimer's disease, and the intermediates useful in preparing the compounds of Formula I.

  本发明提供了公式I的N-环磺酰胺化合物和盐，其中A如规范所述，R1和R2结合形成[3.3.1]或[3.2.1]环系统，其中氮原子连接到两个桥头碳原子，并且[3.3.1]或[3.2.1]环系统可以与杂环芳基或杂环烷基环融合。公式I的化合物可用于治疗或预防认知障碍，如阿尔茨海默病。本发明还包括包含公式I化合物的制药组合物，治疗认知障碍的方法，如阿尔茨海默病，以及制备公式I化合物的中间体。
• Bridged N-Bicyclic Sulfonamido Inhibitors of Gamma Secretase
  申请人：Konradi Andrei W.

  公开号：US20110178119A1

  公开（公告）日：2011-07-21

  The invention provides N-bicyclic sulfonamido compounds of Formula (I) wherein A is as described in the specification and R 1 and R 2 combine to form a [3.3.1] or a [3.2.1] ring system. Compounds of Formula I are useful in treating or preventing cognitive disorders, such as Alzheimer's Disease. The invention also encompasses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of treating cognitive disorders, such as Alzheimer's disease.

  本发明提供了公式（I）的N-双环磺酰胺化合物，其中A如说明书所述，R1和R2结合形成[3.3.1]或[3.2.1]环系统。公式I的化合物在治疗或预防认知障碍，如阿尔茨海默病方面具有用途。本发明还包括含有公式（I）的药物组合物以及治疗认知障碍，如阿尔茨海默病的方法。